Source-linked AI summary

From Knowledge Generation to Knowledge Verification: Examining the BioMedical Generative Capabilities of ChatGPT

Ahmed Abdeen Hamed, Alessandro Crimi, Magdalena M. Misiak, Byung Suk Lee

arXiv:2502.14714v2cs.AIcs.CLcs.IR

TL;DR

ChatGPT’s generative capabilities raise concerns about the reliability and scientific authenticity of the knowledge it produces. The study generates disease-centric associations and verifies terms with biomedical ontologies, links against PubMed, and consistency across ChatGPT models. Reported coverage rates: across three periods, disease-drug 86%, 88%, 90%; disease-gene 83%, 83%, 89%; disease-symptom 49%, 53%, 62%; additional respective ranges: 1%–15%, 1%–4%, 2%–29%.

  • Problem

    ChatGPT’s generative capabilities raise concerns about the reliability and scientific authenticity of the knowledge it produces.

    Source: §1 · p. 4
  • Method

    The study generates disease-centric associations and verifies terms with biomedical ontologies, links against PubMed, and consistency across ChatGPT models.

    Source: §2.2 · p. 5, §4.2 · p. 9, §4.3 · p. 10
  • Results

    Reported coverage rates: across three periods, disease-drug 86%, 88%, 90%; disease-gene 83%, 83%, 89%; disease-symptom 49%, 53%, 62%; additional respective ranges: 1%–15%, 1%–4%, 2%–29%.

    Source: §5.3 · p. 16, §5.4 · pp. 18–19
  • Takeaways & Limitations

    Because ontologies verify association terms rather than the links between them, the study also checks associations against biomedical literature such as PubMed.

    Source: §4.3 · p. 10, §5.3 · p. 16

    Symptom verification is constrained by language discrepancies: generated lay descriptions can be difficult to match to specialist ontology terms.

    Source: §6.1 · p. 21

Abstract

from arXiv · show

The generative capabilities of LLM models offer opportunities for accelerating tasks but raise concerns about the authenticity of the knowledge they produce. To address these concerns, we present a computational approach that evaluates the factual accuracy of biomedical knowledge generated by an LLM. Our approach consists of two processes: generating disease-centric associations and verifying these associations using the semantic framework of biomedical ontologies. Using ChatGPT as the selected LLM, we designed prompt-engineering processes to establish linkages between diseases and related drugs, symptoms, and genes, and assessed consistency across multiple ChatGPT models (e.g., GPT-turbo, GPT-4, etc.). Experimental results demonstrate high accuracy in identifying disease terms (88%-97%), drug names (90%-91%), and genetic information (88%-98%). However, symptom term identification was notably lower (49%-61%), due to the informal and verbose nature of symptom descriptions, which hindered effective semantic matching with the formal language of specialized ontologies. Verification of associations reveals literature coverage rates of 89%-91% for disease-drug and disease-gene pairs, while symptom-related associations exhibit lower coverage (49%-62%).

Graphical Abstract

The graphical abstract depicts the knowledge generation and verification tasks performed.

  • Figure 1 is a graphical abstract of the knowledge generation and verification tasks performed.Source: Figure 1 · p. 3

1. Background and Significance

The paper addresses concerns about the reliability of ChatGPT-generated knowledge by developing approaches to verify the factuality of biomedical associations. It evaluates generated content using biomedical ontologies and PubMed abstracts.

  • LLMs can accelerate tasks, but their generated knowledge raises concerns about reliability and scientific authenticity.Source: §1 · p. 4
  • The paper focuses on verifying the factuality of ChatGPT-generated biomedical associations using relevant ontologies and PubMed abstracts.Source: §1 · p. 4
  • The authors previously introduced xFakeSci to distinguish fake or AI-generated articles from real publications with high precision.Source: §1 · p. 4

2. Introduction

The introduction situates fact-checking in the broader response to misinformation and generative AI, then sets objectives for testing and verifying ChatGPT-generated biomedical associations.

2. Introduction

  • Fact-checking and knowledge verification are presented as safeguards against hallucination and misinformation in generative AI, especially in biomedical applications.Source: §2 · p. 4

2.1. Literature review

  • Prior work spans misinformation research, automated fact-checking, verification of generated content, biomedical LLM applications, and news and multilingual settings.The review describes approaches including external-resource cross-checking, radiology-report checks, sentence-level factuality assessment, and retrieval-augmented generation [29] [31].Source: §2.1 · pp. 4–5

2.2. Goal and objectives

  • The study aims to test ChatGPT’s generation of disease-centric biomedical terms and associations, ontology-based term verification, PubMed verification, and consistency across four ChatGPT models.Source: §2.2 · p. 5

3. Experiment Tasks

The experiment separates term identity checks, association reliability checks, and cross-model consistency checks for generated biomedical knowledge.

  • Task 1 checks generated biomedical terms against relevant ontologies; an unverified term is not necessarily invalid because ontology coverage may be incomplete.Source: §3 · p. 5
  • Task 2 treats associations as binary relations between term categories, such as disease and gene terms.A pair in the disease-gene relation represents a gene associated with a specific disease.Source: §3 · pp. 5–6
  • Task 3 compares associations generated from simulated abstracts across ChatGPT models with the original associations from Task 2.Source: §3 · p. 6

4. Experiment Methods

The methods generate disease-centric associations with ChatGPT, check their terms against biomedical ontologies, and assess association support through co-occurrence in biomedical literature.

4.1. Data generation via prompt engineering

  • Prompt engineering generated 5,000 disease-linked associations for each of genes, symptoms, and drugs, with ontology identifiers and structured JSON outputs.A one-shot prompt example requests ten disease-symptom associations and checks whether the response is valid JSON.Source: §4.1 · pp. 6, 8

4.2. Term correctness verification against biomedical ontologies

  • Terms were checked against specialized ontologies for diseases, drugs, genetic knowledge, and symptoms, using ontology names and synonyms for semantic verification.The ontologies are DOID, ChEBI, GO, and SYMP, respectively.Source: §4.2 · pp. 9–10

4.3. Association reliability verification against biomedical literature

  • Association reliability was assessed by searching contextual PubMed abstract datasets for co-occurrence of disease-drug, disease-gene, or disease-symptom pairs.Coverage is the number of PubMed abstracts containing an association; ontologies verify terms but cannot verify the association itself.Source: §4.3 · pp. 10–11

5. Experiment Results

The experiments tested ontology matching of generated biomedical terms, PubMed coverage of disease-centric associations, and consistency across ChatGPT-generated abstracts. PubMed coverage rose over time, while simulated-abstract coverage was lower and varied by association type.

5.1. Task 1 – Verification of the correctness of biomedical terms

  • Task 1 checked generated terms against DOID, ChEBI, SYMP, and GO, using ontology names and synonyms for literal and semantic matching.Source: §5.1 · p. 12, Table 2 · p. 14

5.2. Tasks 1.1 – Verification of disease terms

  • Combined disease-name verification reached 98% for disease-drug and 99% for disease-symptom links; disease-gene terms had 88% literal and 97% semantic verification.Literal and semantic matching verified 93% and 87% of disease-drug terms, and 97% and 82% of disease-symptom terms; combined matching was omitted for disease-gene terms.Source: §5.2 · p. 12

5.2.1. Tasks 1.2 – Verification of non-disease terms

  • Drug names reached 91% combined verification (90% literal; 90% synonym), symptoms 61% combined (49% literal; 25% additional semantic), and gene names and processes 80% and 97%.Symptom matching was notably lower; the authors note that symptom terms not identified by the ontology also showed improved association-link coverage in the literature search.Source: §5.2.1 · p. 13

5.3. Task 2: Verification of the reliability of biomedical association links

  • Across three periods, disease-drug coverage was 86%, 88%, and 90%; disease-gene coverage 83%, 83%, and 89%; disease-symptom coverage 49%, 53%, and 62%; genetic process-gene coverage rose from 23% to 83% and 89%.Source: §5.3 · p. 16

5.4. Task 3: Verification of the association consistency against ChatGPT-simulated Abstracts by various models

  • In simulated abstracts, coverage was 1%–15% for disease-drug, 1%–4% for disease-gene, and 2%–29% for disease-symptom associations.Approximately 5,000 abstracts were generated per model; symptom associations had the highest match rates in this evaluation, contrasting with their lower performance against biomedical literature, and require further validation.Source: §5.4 · pp. 18–20, Table 5 · p. 19

6. Discussion

The discussion reports high literature coverage for some associations while identifying symptom terminology as a major obstacle to ontology matching. It also examines low-coverage associations, publication timing, and cross-model consistency.

6. Discussion

  • The study uses prompt engineering to generate disease-centered associations linking diseases with symptoms, drugs, and genetic information, then checks them against ontologies and PubMed abstracts.It treats each association as a building block for more complex biomedical models.Source: §6 · pp. 20–21

6.1. Term correctness verification

  • Symptom matching was hindered by lay language, verbosity, combined symptoms, punctuation inconsistencies, and missing ontology synonyms.Examples include “itchy blisters” versus “blister” and “rapid weight loss” versus “weight loss.”Source: §6.1 · p. 21

6.2. Association reliability and consistecny verification

  • Some disease–drug and disease–gene associations had very high literature coverage, including diabetes mellitus–insulin and breast cancer–ATM.The cited examples had 3000+ and 9000 co-occurrences, respectively.Source: §6.2 · p. 21

6.3. Association consistency verification

  • Single-abstract hits may be coincidental, although investigation found non-small-cell lung cancer–lapatinib correct and linked it to drug-repurposing evidence.The passage also notes lapatinib’s use for breast cancer with capecitabine.Source: §6.3 · pp. 21–22
  • Hypertensive heart disease–losartan had weak literature coverage, despite published treatment evidence from Xu et al. and Suzuki et al..The publications appeared during 2009–2015; the authors hypothesize ChatGPT may have drawn on another source.Source: §6.3 · p. 22
  • Associations from 2020–2024 publications had more coverage than older ones, with coverage significantly lower for publications at least a decade old.The generated associations in the losartan examples were found only in older literature.Source: §6.3 · p. 22
  • Associations appeared in independently generated, generic simulated abstracts across models, though overlap with the original associations was low.The authors interpret this as evidence that generation was grounded rather than random.Source: §6.3 · p. 22

7. Future Directions

The authors propose improving symptom verification with semantic-similarity and self-consistency methods, broadening data and models, and using literature-guided generation to explore associations.

Symptom verification

  • An LLM-driven semantic-similarity approach and self-consistency checks within or across models are proposed to improve symptom verification and disease–symptom associations.The authors also propose social-media data on adverse drug reactions and side effects as a possible extension.Source: §7 · p. 22

Models and association generation

  • The authors plan to test open-source models to address cost limitations and improve unsupervised prompt-engineered association generation using biomedical literature.Proposed models include Phi-3, Llama, QWen2.5, and TiniZero.Source: §7 · p. 22
  • Retrieval-augmented generation could supply relevant publications and use one document at a time for in-context prompt engineering aimed at factuality and explainability.The authors expect these approaches to increase confidence in generated knowledge and verification outcomes.Source: §7 · pp. 22–23

Exploring identified associations

  • The authors propose using verified associations and PubMed abstracts to prompt exploration of related facts, then verifying outputs and building literature-driven heterogeneous mirror networks.The proposed exploration includes drug targets, side effects, alternatives, mechanisms, interactions, combinations, and repurposing evidence.Source: §7 · p. 23

8. Declaration of generative AI and AI-assisted

The authors used ChatGPT to generate associations and simulated articles for the study datasets and to format the work, while writing the paper themselves.

Declaration of generative AI and AI-assisted

  • ChatGPT generated study associations and simulated articles and assisted with LaTeX formatting; the authors wrote the paper without generative-AI writing assistance.Source: §8 · p. 23
Loading 2502.14714v2…